Raymond James Financial Services Advisors’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28,191
| Closed | -$836K | – | 3535 |
|
|
2023
Q4 | $836K | Sell |
28,191
-2,889
| -9% | -$57.5K | ﹤0.01% | 2098 |
|
|
2023
Q3 | $493K | Sell |
31,080
-1,568
| -5% | -$26.1K | ﹤0.01% | 2337 |
|
|
2023
Q2 | $616K | Sell |
32,648
-22,291
| -41% | -$263K | ﹤0.01% | 2222 |
|
|
2023
Q1 | $211K | Buy |
54,939
+4,832
| +10% | +$20.6K | ﹤0.01% | 2875 |
|
|
2022
Q4 | $249K | Buy |
50,107
+29,261
| +140% | +$159K | ﹤0.01% | 2714 |
|
|
2022
Q3 | $100K | Buy |
20,846
+865
| +4% | +$4.56K | ﹤0.01% | 2996 |
|
|
2022
Q2 | $90K | Sell |
19,981
-6,440
| -24% | -$28K | ﹤0.01% | 3029 |
|
|
2022
Q1 | $126K | Buy |
26,421
+4,548
| +21% | +$25.2K | ﹤0.01% | 3069 |
|
|
2021
Q4 | $162K | Sell |
21,873
-496
| -2% | -$3.08K | ﹤0.01% | 3046 |
|
|
2021
Q3 | $127K | Sell |
22,369
-1,182
| -5% | -$6.83K | ﹤0.01% | 3081 |
|
|
2021
Q2 | $155K | Sell |
23,551
-3,399
| -13% | -$23.7K | ﹤0.01% | 3069 |
|
|
2021
Q1 | $218K | Sell |
26,950
-2,269
| -8% | -$18.5K | ﹤0.01% | 2854 |
|
|
2020
Q4 | $188K | Buy |
29,219
+11,351
| +64% | +$66.2K | ﹤0.01% | 2737 |
|
|
2020
Q3 | $64K | Buy |
17,868
+492
| +3% | +$1.99K | ﹤0.01% | 2744 |
|
|
2020
Q2 | $80K | Sell |
17,376
-968
| -5% | -$4.12K | ﹤0.01% | 2669 |
|
|
2020
Q1 | $63K | Buy |
18,344
+1,195
| +7% | +$5.22K | ﹤0.01% | 2292 |
|
|
2019
Q4 | $88K | Sell |
17,149
-686
| -4% | -$2.33K | ﹤0.01% | 2716 |
|
|
2019
Q3 | $43K | Buy |
17,835
+1,151
| +7% | +$3.06K | ﹤0.01% | 2710 |
|
|
2019
Q2 | $36K | Buy |
16,684
+894
| +6% | +$2.11K | ﹤0.01% | 2762 |
|
|
2019
Q1 | $43K | Buy |
15,790
+221
| +1% | +$957 | ﹤0.01% | 2713 |
|
|
2018
Q4 | $75K | Sell |
15,569
-1,612
| -9% | -$9.78K | ﹤0.01% | 2431 |
|
|
2018
Q3 | $163K | Buy |
17,181
+1,268
| +8% | +$12.2K | ﹤0.01% | 2585 |
|
|
2018
Q2 | $155K | Sell |
15,913
-20,153
| -56% | -$212K | ﹤0.01% | 2542 |
|
|
2018
Q1 | $379K | Buy |
36,066
+23,982
| +198% | +$237K | ﹤0.01% | 1900 |
|
|
2017
Q4 | $77K | Sell |
12,084
-10,564
| -47% | -$65.2K | ﹤0.01% | 2404 |
|
|
2017
Q3 | $173K | Buy |
22,648
+4,942
| +28% | +$32.8K | ﹤0.01% | 2317 |
|
|
2017
Q2 | $126K | Buy |
+17,706
| New | +$81K | ﹤0.01% | 2317 |
|
Other funds holding IMGN
Raymond James Financial Services Advisors's IMGN Position: Q1 2024 in Review
Raymond James Financial Services Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 28,191 shares — an estimated $836K sold.
Raymond James Financial Services Advisors first reported a position in IMGN in Q2 2017 and held it in 27 quarters. The position peaked at $836K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Raymond James Financial Services Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 28,191 Immunogen Inc shares in Q1 2024, an estimated $836K.
- Raymond James Financial Services Advisors first reported a position in Immunogen Inc in Q2 2017 and held it in 27 quarters.
- Raymond James Financial Services Advisors's Immunogen Inc position peaked at $836K in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.